Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Mazzara

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2001
The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individualsM M Addo, M Altfeld, E S Rosenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2000
Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I alleleS Gnjatic, Y Nagata, E Jager, et al.
Nature Medicine|May 6, 1999
Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizationsH L Robinson, D C Montefiori, R P Johnson, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2001
The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individualsM M Addo, M Altfeld, E S Rosenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2000
Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I alleleS Gnjatic, Y Nagata, E Jager, et al.
Nature Medicine|May 6, 1999
Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizationsH L Robinson, D C Montefiori, R P Johnson, et al.
Pageof 3